Edwards Lifesciences Corp logo

Edwards Lifesciences Corp

€ 88.96 (+1.11%) Oct 6
P/E:
37.71
P/B:
9.09
Market Cap:
€ 54.10B ($ 53.06B)
Enterprise V:
€ 53.26B ($ 52.24B)
Volume:
-
Avg Vol (2M):
2.00
Also Trade In:
Volume:
-
Market Cap €:
54.10B
Market Cap $:
53.06B
PE Ratio:
37.71
Avg Vol (2-Month):
2.00
Enterprise Value €:
53.26B
Enterprise Value $:
52.24B
PB Ratio:
9.09
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.
Name Current Vs Industry Vs History
Cash-To-Debt 2.22
Equity-to-Asset 0.71
Debt-to-Equity 0.12
Debt-to-EBITDA 0.36
Interest Coverage 2178.27
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 15.86
Distress
Grey
Safe
Beneish M-Score -2.51
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 61.32
9-Day RSI 51.77
14-Day RSI 47.75
6-1 Month Momentum % -16.71
12-1 Month Momentum % -3.85

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.37
Quick Ratio 2.6
Cash Ratio 1.56
Days Inventory 226.66
Days Sales Outstanding 42.21
Days Payable 49.69

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.1

Financials (Next Earnings Date:2022-10-27 Est.)

WBO:EWLS's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 4,807.974
EPS (TTM) (€) 2.079
Beta 0.44
Volatility % 32.53
14-Day RSI 47.75
14-Day ATR (€) 1.65553
20-Day SMA (€) 89.535
12-1 Month Momentum % -3.85
52-Week Range (€) 82.59 - 119
Shares Outstanding (Mil) 619.94

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Edwards Lifesciences Corp Filings

Document Form Filing Date
No Filing Data

Edwards Lifesciences Corp Analysis

Share your research